Haoxi Health Raises $6.5 Million via $0.25 Direct Offering of Shares and Warrants
HAO•Haoxi Health Technology has agreed to sell 9 million Class A shares and 17 million pre-funded warrants at $0.25 each in a registered direct offering to raise approximately $6.5 million. Net proceeds will fund working capital and general corporate purposes, with closing expected on or about May 12, 2026.
1. Offering Structure
Haoxi Health Technology will issue 9,000,000 Class A ordinary shares and 16,999,998 pre-funded warrants at $0.25 per unit, with each warrant exercisable to purchase 10.355 shares at an exercise price of $0.0026 per share.
2. Use of Proceeds
The company expects to receive approximately $6.5 million in gross proceeds before commissions and expenses, which will be used for working capital and general corporate needs to support its online marketing operations.
3. Closing Conditions
The registered direct offering is being made under an effective Form F-3 shelf registration, with Univest Securities serving as placement agent, and is slated to close on or about May 12, 2026, pending customary closing conditions.
